Catherine Bonuccelli

Dr. Catherine Bonuccelli is a Johns Hopkins trained pediatric pulmonologist with over 25 years of pharmaceutical experience and deep expertise in clinical and product development of both respiratory and non-respiratory products across all phases of drug development. Prior to establishing CMB Life Sciences Consulting LLC, she was the CMO for Bellus Health, where she advanced an asset for refractory chronic cough into Phase 3 prior to the company’s acquisition by GSK. During her more than 20-year tenure with AstraZeneca, she held a broad variety of roles of increasing responsibility, including Global Medicines Clinical Vice President for the Inflammation, Neuroscience, & Respiratory Therapeutic Area, and Therapy Area Clinical Vice President, Respiratory and Inflammation. She then spent more than four years serving as the US  Respiratory Therapeutic Area Head for GlaxoSmithKline before joining Bellus Health.

Dr. Bonuccelli earned her B.S. in Chemistry from Georgetown University and her M.D. from the Johns Hopkins University School of Medicine, where she also completed her internship, residency, and fellowship before entering academia at the University of Virginia.  She subsequently moved to Wilmington DE to join Zeneca Pharmaceuticals to develop a first-in-class asthma therapy.  Over the course of her career, Dr. Bonuccelli has been a member of multiple bioscience- and health-related boards, including those for the Biotechnology Organization, Delaware Biotechnology Park, A.I. Dupont Hospital for Children, and the American College of Physicians Foundation.